MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$62 | -$33 | -$26 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $2 | $0 |
| Change in WC | $5 | -$1 | $1 |
| Other Non-Cash | -$3 | -$1 | $1 |
| Operating Cash Flow | -$55 | -$32 | -$23 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$239 | -$64 | -$20 |
| Inv. Sales/Matur. | $80 | $33 | $9 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$161 | -$31 | -$11 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $10 |
| Stock Issued | $175 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $60 | $69 | $36 |
| Financing Cash Flow | $234 | $69 | $46 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $19 | $6 | $12 |
| Supplemental Information | – | – | – |
| Beg. Cash | $31 | $24 | $13 |
| End Cash | $49 | $31 | $24 |
| Free Cash Flow | -$56 | -$32 | -$24 |